Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients.

類似資料

• The clinical significance of soluble human leukocyte antigen class-I, ICTP, and RANKL molecules in multiple myeloma patients.
  著者:: Schütt, P, 等
  出版事項: (2008)
• Thalidomide in combination with dexamethasone for pretreated patients with multiple myeloma: serum level of soluble interleukin-2 receptor as a predictive factor for response rate and for survival.
  著者:: Schütt, P, 等
  出版事項: (2005)
• In vitro dendritic cell generation and lymphocyte subsets in myeloma patients: influence of thalidomide and high-dose chemotherapy treatment.
  著者:: Schütt, P, 等
  出版事項: (2005)
• Immune parameters in multiple myeloma patients: influence of treatment and correlation with opportunistic infections.
  著者:: Schütt, P, 等
  出版事項: (2006)
• MICA-129 Dimorphism and Soluble MICA Are Associated With the Progression of Multiple Myeloma
  著者:: Alessandra Zingoni, 等
  出版事項: (2018-05-01)